Saturday, July 11, 2026

pharma · Convalescence

Te Arai BioFarma

Te Arai BioFarma is a pharma organization headquartered in AU. Primary therapeutic focus areas include Convalescence. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity f

Melbourne, AU HQ
2012 Founded
4 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2012
Employees
4
Programs
1
Drugs
0
Patents
0
Clinical program

Convalescent plasma

Phase 1 · mab · Convalescence

Convalescent plasma for Convalescence is a Phase 1 program (mab) at Te Arai BioFarma Limited with 1 ClinicalTrials.gov record(s).

Internal code 3471041S322342020040800002

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Te Arai BioFarma Limited
Phase
Phase 1
Modality
mab
Indication
Convalescence
Status
completed
Trials
1

Clinical trials